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Dhh1 is a highly conserved DEAD-box protein that has been
implicated in many processes involved in mRNA regulation. At
least some functions of Dhh1may be carried out in cytoplasmic
foci called processing bodies (P-bodies). Dhh1 was identified
initially as a putative RNA helicase based solely on the presence
of conserved helicase motifs found in the superfamily 2 (Sf2) of
DEXD/H-box proteins. Although initial mutagenesis studies
revealed that the signature DEAD-box motif is required for
Dhh1 function in vivo, enzymatic (ATPase or helicase) or ATP
binding activities of Dhh1 or those of any its many higher
eukaryotic orthologues have not been described. Here we pro-
vide the first characterization of the biochemical activities of
Dhh1. Dhh1 has weaker RNA-dependent ATPase activity than
other well characterized DEAD-box helicases. We provide evi-
dence that intermolecular interactions between the N- and
C-terminal RecA-like helicase domains restrict its ATPase
activity; mutation of residues mediating these interactions
enhanced ATP hydrolysis. Interestingly, the interdomain inter-
action mutant displayed enhanced mRNA turnover, RNA bind-
ing, and recruitment into cytoplasmic foci in vivo compared
with wild type Dhh1. Also, we demonstrate that the ATPase
activity of Dhh1 is not required for it to be recruited into cyto-
plasmic foci, but it regulates its association with RNA in vivo.
We hypothesize that the activity of Dhh1 is restricted by inter-
domain interactions, which can be regulated by cellular factors
to impart stringent control over this very abundant RNA
helicase.
The regulation of gene expression in eukaryotes is a com-
plex series of events that is well coordinated by different
cellular machineries. Central to this process is the regulation
of mRNA metabolism. It begins with transcription followed
by pre-mRNA processing in the nucleus, nucleo-cytoplasmic
transport, translation, and finally, the controlled degrada-
tion of mRNA.
mRNA degradation is one of the important means of mRNA
quality control. In eukaryotic cells two major pathways have
evolved for mRNA degradation; they are non-sense-mediated
decay, which is deadenylation-independent and themore ubiq-
uitously used deadenylation-dependent pathway (1). Non-
sense-mediated decay is the process of choice for quick and
efficient removal of transcripts with non-sense codons,
unspliced introns, or extended 3-UTR (2). The deadenylation-
dependent pathway begins with the removal of the 3-poly(A)
tail by 3-5 exonucleases Ccr4 and Pop2 or poly(A) nuclease
(3–7). This is followed by removal of the 5-m7-guanosine
triphosphate cap by the Dcp2/Dcp1 decapping complex (8, 9).
The binding of Dcp1/Dcp2 to the 5 cap and decapping are
enhanced by a complex of seven Lsm (like-Sm) proteins (Lsm1
through Lsm7), Pat1, Edc3, andDhh1 (10–17). The final step in
the pathway involves degradation of the decapped and de-
adenylated RNA by the 5-3 exonuclease Xrn1 and by the exo-
some that acts in the 3-5 direction (16, 17). Proteins involved
in mRNA turnover are localized to distinct foci in the cyto-
plasm called processing bodies (P-bodies) or GW bodies (18–
20). Although the formation of P-bodies have been initially
associated with mRNA decay and storing translationally
repressed RNA, recent studies have shown that they not termi-
nal centers of RNA degradation, as a subset of translationally
repressed RNA can reenter the active pool in response to cellu-
lar signals (11, 21–23).
One of the factors important for mRNA degradation and
translational repression in yeast is the abundant DEAD-box-
containing protein, Dhh1. Dhh1 localizes to P-bodies and stim-
ulates mRNA decapping, possibly by interacting with the
decapping enzyme Dcp1p (11, 24, 25). Dhh1, along with its
interacting partners Pat1 and Edc3, is also involved in transla-
tional repression of mRNAs and has been shown to sequester
RNAs into a non-translating pool that does not undergo degra-
dation (22, 25, 26). Studies have linked Dhh1 to cell cycle regu-
lation, where it is important for G1/S DNA-damage checkpoint
recovery in Saccharomyces cerevisiae (27, 28). Recent studies
have also shown that Dhh1 controls hyphal development (29).
Thus, although not essential for normal cell growth, this pro-
tein plays a number of important functions.
Dhh1 also interacts with the evolutionary conserved Ccr4-
Not complex (30, 31). Multiple roles have been assigned to the
Ccr4-Not complex in regulating the life of mRNAs (32–34).
First identified as a complex regulating transcription initiation,
it was later shown that the Ccr4 subunit is the major poly(A)
deadenylase (5, 6). Although the later observations raised ques-
tions about the function of Ccr4-Not in transcription, we
recently confirmed that the Ccr4-Not complex interacts with
elongating RNAPII and directly regulates transcription elonga-
tion (35). It appears that the Ccr4-Not complex, and not Ccr4
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specifically, regulatesmRNAdecay because even theNot group
of proteins has been found localized to P bodies and regulates
mRNA half-lives (36). Thus, this complex provides a link to
transcription in the nucleus andmRNAdecay in the cytoplasm.
Dhh1 shows exceptional sequence conservation. For exam-
ple, the human orthologue of Dhh1, Ddx6 (rck/p54), bears a
69% identity and 83% similarity to Dhh1. Ddx6 can comple-
ment the phenotypes of a dhh1 mutant (27), suggesting they
play similar roles in regulating cell function in their respective
organisms. Dhh1 belongs to the superfamily 2 (Sf2) of DEXD/
H-box proteins (37). Sf2 helicases contain nine conserved heli-
case motifs. DEXD/H-box proteins have been reported to be
components of various cellular machineries that regulate
mRNA metabolism and are involved in mRNA splicing, trans-
port, translation, decay, ribosome biogenesis, and transcription
in both eukaryotes and prokaryotes (38–41). Many of these
functions have been attributed to the ability of these proteins to
act as helicases and disrupt RNA secondary structure. In addi-
tion, several DEXD/H-box proteins are shown to displace pro-
tein factors from single-stranded RNAwithout duplex unwind-
ing (42, 43). The crystal structure of the core domain of Dhh1
was recently solved, and its domain structure compares well
with that of other DEAD-box helicases like S. cerevisiae eIF4A,
MjDEAD,Drosophila melanogaster Vasa, and hepatitis C virus
NS3 (44). However, there are distinct differences in the relative
orientation of the two globular (RecA-like) domains in Dhh1
compared with other DEXD/H proteins. It was proposed that
interdomain interactions within Dhh1 might regulate its activ-
ity (44). The structure of Dhh1 has been insightful in predicting
domain orientations and key residues that may be involved in
enzymatic function; however, enzymatic activities of Dhh1
have not been observed. Many questions remain as to how the
various biochemical activities of Dhh1 regulate the multiple
functions of this important helicase. Specifically, does the
unusual conformation of the Dhh1 predicted from the crystal
structure regulate its biochemical activities and its cellular
functions in vivo?
Here we provide the first analysis of Dhh1 ATPase and ATP
binding activities and have identified key residues involved in
ATP andRNAbinding andATPhydrolysis. Interestingly, Dhh1
has weaker ATPase activity compared with other DEAD-box
helicases, and we present data arguing that the intermolecular
interactions between the N- and C-terminal domains restrict
its ATPase activity. Disruption of these interactions through
mutagenesis increases ATP hydrolysis and enhances its mRNA
metabolism andmRNAbinding functions in vivo. Based on our
results, we hypothesize that Dhh1 activity is restricted by
interdomain interactions, which can be regulated by cellular
factors to impart stringent control over this very abundant
RNA helicase.
EXPERIMENTAL PROCEDURES
Nucleotides—The 3 fluorescein-labeled oligonucleotides for
RNA binding assays and RNA oligonucleotides for helicase
assays were purchased from Dharmacon Research Dharmacon
Research, Inc. (Lafayette, CO). DNA oligonucleotides used for
mutagenesis were from Integrated DNA Technologies Inc.
(Coralville, IA) or Invitrogen. [-32P]ATP (6000 Ci/mmol) was
from PerkinElmer Life Sciences. [-32P]ATP, [-32P]UTP,
[-32P]CTP, [-32P]GTP, and [-32P]dATP (3000 Ci/mmol)
were from PerkinElmer Life Sciences. Nucleotides were
obtained from GE Healthcare. AMP-PNP,2 ADP, poly(U),
poly(G), poly(C), and poly(A) were obtained from Sigma.
RNA oligonucleotides were purified on denaturing 8 M urea
polyacrylamide gels. Concentrations were determined by
measuring the absorbance at 260 nm using a Nanodrop spec-
trophotometer and using the appropriate calculated extinc-
tion coefficient.
Expression andPurification of RecombinantDhh1—The cod-
ing sequence of DHH1 was amplified by PCR and cloned into
pRSET-A (Invitrogen) to express the protein with a hexahisti-
dine tag (His6) at theN terminus of the protein. This introduces
an additional 37 amino acids, including the His6 into the pro-
tein. Mutant proteins were generated by PCR-generated site-
directed mutagenesis. Dhh1 was expressed in Escherichia coli
BL21-DE3 pLysS cells. Expression was induced with 1.0 mM
isopropyl 1-thio--D-galactopyranoside for 4 h at room tem-
perature. The cells were harvested, and the cell pellet was resus-
pended in 20 ml of buffer A (20 mM Tris-HCl (pH 7.4), 500 mM
NaCl, 0.1% Triton X-100, and 10% glycerol) containing 100 M
PMSF, pepstatin, leupeptin, and chymostatin (5 g/ml each), 1
mMbenzamidine hydrochloride, and 10mM imidazole. The cell
suspension was sonicated on ice using a Branson Sonifer. The
resulting cell lysate was clarified by centrifugation at 16,000
rpm for 30 min. The supernatant was incubated with NTA-
cobalt-agarose (Clontech, Mountain View, CA) for 1 h at 4 °C.
The resin was packed into a column and washed with 50 ml of
buffer A containing 10 mM imidazole followed by a wash with
Buffer A containing 20 mM imidazole. The protein was eluted
using 250 mM imidazole in buffer B (20 mM Tris-HCl (pH 7.4),
250mMNaCl, 0.1% Triton X-100, and 10% glycerol) containing
100 M PMSF and 1mM benzamidine hydrochloride. The peak
fractions were pooled and dialyzed against 2 liters of buffer C
(20 mM HEPES-NaOH (pH 7.4), 75 mM NaCl, 10% glycerol).
The dialyzed sample was passed over a SP-Sepharose column.
The column was washed with 20 ml of buffer C followed by 10
ml of buffer D (20 mM HEPES-NaOH (pH 7.4), 150 mM NaCl,
10% glycerol). The protein was eluted using buffer E (20 mM
HEPES-NaOH (pH 7.4), 500mMNaCl, 10% glycerol). The pure
fractions were pooled and dialyzed against 2 liters of buffer B
containing 1mM dithiothreitol, 0.5mM EDTA. The protein was
stored at 80 °C.
ATPase Assay—ATPase assays were typically performed at
30 °C in 25 mM MOPS (pH 7.0), 50 mM NaCl, 10 mM MgCl2, 4
MDhh1, 50 M ATP, 4 Ci of [-32P]ATP, and 10 g of poly-
nucleotide substrates (Sigma). Reactions were initiated by the
addition of ATP and quenched with EDTA after 1 h. Specific
concentrations of substrate or enzyme along with any devia-
tions from the above are indicated in the legends to Figs. 1 and
2. 3 l of the quenched reaction was spotted onto PEI-cellulose
TLC plates (EM Science, Gibbstown, NJ). TLC plates were
2 The abbreviations used are: AMP-PNP, adenosine 5-(,-imino)triphos-
phate; mP, fluorescence polarization; SD, synthetic drop out; RIP, RNA
immunoprecipitation; IP, immunoprecipitate; NTA, nickel-nitrilotriacetic
acid; RFP, red fluorescent protein.
Characterization of the DEAD-box Protein Dhh1
















developed in a buffer containing 40mMLiCl and 100mM formic
acid, dried, and exposed to a PhosphorImager screen. TLC
plates were visualized by using a PhosphorImager and quanti-
fied using the ImageQuant software (GE Healthcare) to deter-
mine the amount of ATP hydrolyzed to ADP and Pi. The pmol
of ATP hydrolyzed by Dhh1 in 1 h were determined by calcu-
lating the ratio of released Pi to unhydrolyzed ATP.
Nucleotide Cross-linking—Dhh1 (4 M) was incubated with
10 Ci of -32P-labeled nucleotides in 25 mM MOPS (pH 7.0),
50mMNaCl, 10mMMgCl2 at room temperature for 10min. For
experiments to study competition with cold nucleotides, 100
M ATP, GTP, CTP, UTP, dATP, or ADP were added before
cross-linking. The samples were then UV-cross-linked on ice
(254 nm) for 6 min using a Stratalinker (Stratagene, La Jolla,
CA). The samples were boiled in SDS-PAGE buffer and
resolved in a 10% SDS-PAGE gel. The gels were stained with
Coomassie Blue, dried and exposed to a PhosphorImager
screen for detection. The gels were quantified using the
ImageQuant software (GE Healthcare). The signals were cor-
rected for the amount of protein in each sample.
Nucleic Acid Binding Assay—Experiments were performed
using a Beacon fluorescence polarization system (GE Health-
care). Assays were performed by mixing 0.1 nM 3-fluorescein-
labeled poly(U) with increasing amounts of Dhh1 in binding
buffer (25 mM MOPS (pH 7), 2 mM -mercaptoethanol, 10 mM
MgCl2, and 50mMNaCl) followed bymonitoring the change in
fluorescence polarization (mP). The volume of Dhh1 or buffer
added to the binding reaction was equal to 1⁄10 the total reaction
volume. All steps were performed in reduced light. To deter-
mine the dissociation constant (Kd), mP was plotted as a func-
tion of Dhh1 concentration, and the data were fit to a hyperbola




 mP0 (Eq. 1)
The above equation represents the equation of a rectangular
hyperbola, where mP is the observed millipolarization, mPmax
is maximum polarization, mP0 is polarization of RNA alone in
the absence of Dhh1, and Kd,app is the apparent dissociation
constant.
Helicase Assay—Helicase assays were carried out as de-
scribed in a previous publication (45). 5 M RNA oligonucleo-
tides were annealed in 25 mM MOPS (pH 7.0), 50 mM NaCl by
heating to 90 °C for 1 min and slowly cooling to room temper-
ature using a Progene Thermocycler (Techne, Minneapolis,
MN). The ratio of labeled to unlabeled strand was 1:1.2. All
helicase assays were performed at 30 °C. 1 MDhh1 was mixed
with 2nM 32P-labeled unwinding substrate in 25mMMOPS (pH
7.0), 50 mMNaCl, and 1mM EDTA. Reactions were initiated by
the addition of 10mMATP, 10mMMgCl2, and 100 nM trapping
strand (a 9-mer RNA that is complementary to the displaced
strand) in 25 mMMOPS (pH 7.0), 50 mM NaCl. Reactions were
quenched by adding EDTA and SDS to a final concentration of
100 mM and 0.33%, respectively. Products were resolved on
native polyacrylamide gels.
Strains and Media—Strains used in this study are described
in detail in supplemental Table 1). DHH1 containing 800 base
pairs (bp) upstream and 400 bp downstream of the open read-
ing frame was cloned into the yeast centromeric vector pRS414
from the plasmid pRS426-DHH1(46). Mutants of DHH1 were
generated by site-directed mutagenesis using the QuikChange
method. Plasmidswithwild type andmutantDHH1were trans-
formed into strain YJR148 (27) and used in Figs. 4 and 5B. For
the detailed analysis of somemutants, theywere integrated into
the genome. These mutants were cloned into the integrating
vector pRS404, and the resulting plasmid was linearized by
restriction endonuclease digestion and transformed into
YJR148. Integration was confirmed by PCR and protein expres-
sion byWestern blotting. For spot growth assays, cultures were
grown overnight in synthetic drop out (SD) medium lacking
tryptophan and diluted to an A600  1.0. 3-Fold serial dilutions
of the culture were spotted on to SD-tryptophan plates. Gene
deletions were performed as previously described using a PCR-
mediated gene disruption strategy (47). Integrated mutants
were grown in 1% yeast extract, 2% peptone, 2% dextrose
(unless indicated otherwise), and 20 g/ml adenine sulfate.
RNA Isolation and Analysis of RNA by Northern Blotting—
RNA isolation and northern blotting were carried out as previ-
ously described (48). Total RNA (15 g) was separated on 1%
formaldehyde gel and transferred to nitrocellulose membrane
(Hybond-N; Amersham Biosciences) via capillary action.
After UV-cross-linking and a 4-h prehybridization at 65 °C,
radioactively labeled gene-specific probes were added. Signal
was detected using PhosphorImager screen, scanned with the
Typhoon system, and quantified using ImageQuant software
(GE Healthcare). scR1, an RNA polymerase III-transcribed
gene, was used as a loading control.
RNA Immunoprecipitation (RIP)—RIP assays were based on
a previous publication (49), with the changes described below.
Yeast cultures (100 ml) were grown at 30 °C in synthetic drop-
out medium lacking tryptophan and containing 4% dextrose to
an absorbance (600 nm) of 0.8 and then shifted to rich media
containing 1% yeast extract, 2% peptone, 4% dextrose, and 20
g/ml adenine sulfate and grown for 1 h at 30 °C. For the induc-
tion of stress, cells were treated with 0.03% methyl methane
sulfonate for 1 h before cross-linking. Cells were cross-linked
with 1% (v/v) formaldehyde at room temperature for 15 min.
Formaldehydewas quenchedwith glycine (125mM). All buffers
were prepared in diethyl pyrocarbonate-treated water. Cells
were resuspended in 500 l of cold FA-lysis RIP buffer (50 mM
HEPES-KOH (pH 7.5), 150 mM NaCl, 1% Triton X-100, and
0.1% sodium deoxycholate supplemented with 2g/ml leupep-
tin, 3g/ml aprotinin, 2g/ml pepstatin A, 1g/ml chymosta-
tin, 1 mM benzamidine-HCl, 0.5 mM PMSF). The cells were
distributed into two microcentrifuge tubes, and 300 l of glass
beads were added. Tubes were mixed at the highest speed on a
vortex mixer for 45 min at 4 °C. The lysate was transferred to a
15-ml tube and brought up to a volume of 1.8 ml using FA-lysis
RIP buffer. The lysate was sonicated in a Bioruptor sonicator
(Diagenode, Philadelphia) for 2–30-s pulses and then trans-
ferred back into microcentrifuge tubes. The lysates were clari-
fied by two 30-min spins at 14,000 rpm at 4 °C. The protein
concentration of the extracts ranged between 7 and 10 mg/ml.
500 l of the whole cell extract was diluted with an equal vol-
ume of FA-lysis RIP buffer, andMgCl2 andCaCl2 were added to
Characterization of the DEAD-box Protein Dhh1
















25 and 5 mM, respectively. RNase-free DNase I was added to 4
units per ml (Worthington, Lakewood, NJ), and the extract was
incubated for 60 min at 30 °C. EDTA was added to 50 mM, and
the whole cell extract was cooled on ice and centrifuged at
14,000 rpm. An aliquot (100 l) was removed for the input
sample. The remainder was added to tubes containing 20 l of
protein A-Sepharose beads (GE Healthcare) containing the
equivalent of 2 l of anti-Dhh1 polyclonal antiserum. The anti-
body was raised to full-length Dhh1 in rabbits. The beads were
incubated overnight at 4 °C with agitation. The beads were
washed 3 times with FA-lysis RIP buffer, twice using FA-wash
buffer 2 (50mMHEPES-KOH (pH 7.5), 1 mM EDTA, 1% Triton
X-100, 0.1% sodium deoxycholate, 0.5 M NaCl, 0.5 M PMSF, 1
mM benzamidine-HCl), twice using FA-wash buffer 3 (0.25 M
LiCl, 1% Nonidet P-40, 1% sodium deoxycholate, 1 mM EDTA,
10 mM Tris-HCl (pH 8.0), 0.5 M PMSF, 1 mM benzamidine-
HCl), and twice inTEbuffer (10mMTris-HCl, 1mMEDTA).All
washes were performed with ice-cold cold buffers. The
immune complexes were eluted off the beads for 20 min at
65 °C in 450l of elution buffer (25mMTris-HCl (pH7.5), 1mM
EDTA, 0.2 M NaCl, and 0.5% SDS). Proteinase K was added to
100g/ml, and the elutedmaterialwas incubated at 55 °C for 30
min and then 4–5 h at 65 °C to reverse the cross-links. The
RNA was purified by acid-phenol (pH 4.8)/chloroform (1:1)
extraction and ethanol-precipitated in the presence of 20 g
glycogen. The pelletwas resuspended in diethyl pyrocarbonate-
treated water and converted to cDNA using random 9-mer
primers and avian myeloblastosis virus reverse transcriptase as
recommended by the manufacturer (Promega, Madison, WI).
Transcripts were detected using gene-specific primers by semi-
quantitative PCR. The primers to the PYK1 ORF were
described in previous publications (50, 51). PCR products were
analyzed by electrophoresis in agarose gels and ethidium bro-
mide staining, scanned with the Typhoon system (GE Health-
care), and quantified by using ImageQuant software. Percent-
age immunoprecipitate (IP) values were calculated using the
following product: (IP signal/input signal)  100. Background
was determined by conducting the RIP on dhh1 cells, and
these values were subtracted from the specific signals. Error
bars represent the S.E. of at least three repetitions.
Live Cell Imagining of Dhh1—Cells containing wild type or
mutant DHH1-GFP integrated at its original genomic locus
were transformed with a centromeric vector expressingDCP2-
RFP (pRP1186) (52). Yeast cultures were grown to A600 of 0.4–
0.6 in the appropriate synthetic dropout (SD)media. Cells were
collected by brief centrifugation, resuspended in fresh synthetic
dropoutmedium 2%glucose, incubated at room temperature
for 15min, and spun down. Cells were resuspended in 1⁄20 of the
initial volume and spotted on slides. The slides were immedi-
ately examined under a microscope at room temperature. All
images were acquired using an Olympus Fluoview 1000 micro-
scope system running FV1000 Fluoview software, with an
Olympus 100, oil-immersion 1.4 NA objective. Images were
stored as 512  512 pixel files. All experimental images were
captured as Z-stacks of 5–8 images and compiled. ImageJ was
used to measure the number and size of P bodies as described
previously (52).
RESULTS
Dhh1 Has RNA-stimulated ATPase Activity—Recombinant
His6-Dhh1 was expressed in E. coli, isolated on NTA-cobalt
beads, and further purified by SP-Sepharose chromatography.
The use of NTA-cobalt beads and ion-exchange chromatogra-
phy was necessary to purify Dhh1 away from a contaminating
E. coli protein with nucleic acid-stimulated ATPase activity.3
The contaminating ATPase was also stimulated by DNA, indi-
cating that it is not RNA-specific.3 Fig. 1A, shows the purifica-
tion of the protein through the SP column. ATPase assays were
carried out at 30 °C with increasing amounts of poly(U) RNA.
Dhh1 has very lowATPase activity in the absence of RNA, but a
10-fold stimulation in activitywas observed in the presence of
RNA (Fig. 1B).
Although Dhh1 displayed RNA-dependent ATPase activity,
the level of activity was significantly less than that reported for
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FIGURE 1. ATPase activity of Dhh1 is stimulated by RNA. A, purification of recombinant Dhh1 is shown. Recombinant His6-Dhh1 was purified on NTA-cobalt
beads (Talon) followed by SP-Sepharose chromatography. An SDS-PAGE gel shows the different fractions during purification. E1-E4, elutions from NTA-cobalt
beads or SP-Sepharose column. B, ATPase activity of Dhh1 is shown. An ATPase assay was performed at 30 °C for 60 min using 4 M Dhh1 and increasing
amounts of poly(U) (0 –50 g). Results are plotted as pmol of ATP hydrolyzed as a function of increasing poly(U) concentration. The data is shown as the average
and S.E. of three experiments.
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other DEXD/H-box proteins, such as eIF4A and Ded1 (39, 53,
54). Furthermore, a side by-side comparison of the ATPase
activities of Dhh1 and the hepatitis C virus NS3 RNA helicase
suggests that Dhh1 has weaker ATPase than better-studied
DEAD-box proteins (supplemental Fig. 1). The difference in
activity was unexpected because Dhh1 has all of the signature
motifs and conserved catalytic residues found in other well
studied DEXD/H-box proteins. We speculated that there may
be biological significance for the weaker enzymatic activity and
explored the possible causes. The crystal structure of the core
domain of Dhh1 revealed extensive interdomain interactions
between the C-terminal and N-terminal lobes of the protein,
which positions Dhh1 into a closed conformation (44). Such
interactions are lacking in eIF4A and mjDEAD, DEAD-box
proteins with more robust ATPase activity than Dhh1 (see Ref.
44 and supplemental Fig. 2). More specifically, Leu-342 and
Thr-344 of motif V in the C-terminal domain of Dhh1 hydro-
gen bond with Lys-91 of motif I in the N-terminal domain (Fig.
2A). Furthermore, the side chain of Arg-345 in motif V stacks
against that of Arg-89 in motif I and Leu-343 in motif V and
make van der Waals interactions with Gly-93 and Thr-94 in
motif I. Current models propose that binding of ATP and RNA
by DEXD/H-box proteins results in a conformational change,
bringing the C- andN-terminal domains closer, and rotation of
these domains occurs during the ATP hydrolysis cycle (39, 55).
Given the interactions between andN-terminal andC-terminal
RecA-like domains observed in the crystal structure of the core
domain Dhh1, it is possible that these interactions may hinder
the movement of the two domains with respect to each other
and limit ATPase activity. To test this hypothesis, we have
mutated Thr-344 ofmotif V and Lys-91 ofmotif I to alanines to
disrupt the hydrogen bonding between these residues. This is
predicted to weaken the interdomain interactions and may
increase the ATPase activity of the mutant. Furthermore, we
analyzed a mutant in the first conserved aspartic acid in the
“DEAD box” of Dhh1, D195A, as a control and to confirm that
Dhh1 is a bona fide DEAD-box ATPase. As expected, the level
of ATPase activity of the D195Amutant was negligible, and the
FIGURE 2. ATPase activity of Dhh1 is stimulated by the mutation of residues involved in interdomain interactions. A, the crystal structure of Dhh1 with
the locations Lys-91 and Thr-344 indicated in red and blue, respectively. The structure was analyzed using PyMOL software (PDB code 1S2M). B, ATPase activity
of wild type and mutant Dhh1 is shown. ATPase assays were carried at 30 °C for 60 min using 4 M protein and increasing amounts of poly(U) (0 –50 g). Results
are plotted as pmol of ATP hydrolyzed as a function of increasing poly(U) concentration. C, RNA sequence requirement for ATPase activity is shown. ATPase
activity was carried out using 4 M protein and 10 g of RNA indicated in the figure. D, nucleotide specificity of Dhh1 is shown. NTPase activity of wild type and
mutant Dhh1 was carried at 30 °C for 60 min using 4 M protein and 10 g of poly(U) RNA. The data in panels C and D represent an average and S.E. of three
experiments.
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little that was observed may originate from a trace amount of
contaminating E. coli ATPase in our preparations (Fig. 2B). A
double D195A/E196A mutant had a similar amount of activity
as the single D195A mutant (not shown). Interestingly, muta-
tion of both Lys-91 and Thr-344 to alanine residues resulted in
a 2.5–3-fold increase in the ATPase activity over that of wild
type Dhh1 (Fig. 2B). These results support the hypothesis that
disrupting the contacts made between the N- and C-terminal
RecA-like domains of Dhh1 would increase ATPase activity
and suggest that the interdomain interactionsmay limit its abil-
ity to hydrolyze ATP.
Next, we evaluated the RNA sequence and nucleotide speci-
ficity requirements for the ATPase activity of Dhh1. The
ATPase activities of wild type Dhh1 and the D195A and K91A/
T344A mutants were examined in the presence of poly(U),
poly(A), poly(C), and poly(G) ribonucleic acids. As shown in
Fig. 2C, poly(U), poly(A), and poly(C) stimulated the ATPase
activity of Dhh1 to roughly the same degree, but poly(G) was
significantly less effective. However, the ineffectiveness of
poly(G) is most likely due to its propensity to form G-quartets
in solution rather than reflect selectivity againstG residues (56).
Dhh1Displays Specificity for Adenine-containing Nucleotides—
Typical DEAD-box proteins display specificity for adenine-
containing nucleotides and hydrolyze ribose and deoxyribose
versions of adenine nucleotides equally well (39). To provide
further evidence that Dhh1 is a typical DEAD-box ATPase, we
examined the nucleotide specificity of the protein bymeasuring
its ability to hydrolyze and bind to different nucleotides. The
nucleotide specificity for hydrolysis was examined by conduct-
ing NTPase assays in the presence of poly(U) RNA and 50 M
cold nucleotide and a trace amount of corresponding -32P-
labeled versions. We analyzed the DEAD-box and interdomain
interaction mutants (see above) in parallel as controls. As
shown in Fig. 2D, wild type Dhh1 hydrolyzed ATP and dATP,
but not GTP, CTP, or UTP. Similar to what was observed when
ATP was used as a substrate, the K91A/T344A mutant dis-
played enhanced hydrolysis of dATP compared with wild type
protein but no hydrolysis of the other nucleotides. Thus, even
though disrupting the interdomain interactions within Dhh1
enhanced its ATPase activity, these mutations did not alter the
nucleotide specificity of the protein.
The nucleotide binding specificity of Dhh1 was examined by
UV-cross-linking of radiolabeled nucleotides to the protein.
The amount of NTP cross-linked was quantified, and the sig-
nals for each sample were corrected for the amount of protein
in the gel and normalized to the signal fromwild type Dhh1. To
distinguish signals attributed to nucleotide binding versus non-
specific cross-linking, we analyzed a mutant with substitutions
in highly conserved residues within the Q-motif of Dhh1
(F66R/Q73A). The Q-motif, especially the conserved phenyla-
lanine and glutamine residues, has been shown to participate in
nucleotide binding in other DEAD-box proteins, and co-crystal
structures of DEAD-box helicases with nucleotide analogs
revealed that these residuesmake contactwith the adenine base
(57–60). We used the D195A mutant as a control, as this
mutant should bind ATP but not hydrolyze it. It has been
reported that the analogous DEAD-box mutation in eIF4A
enhanced nucleotide cross-linking, presumably by preventing
hydrolysis of the nucleotide (54, 61). If the cross-linking to
Dhh1 is specific, we expect that cross-linking would be reduced
and enhanced in the Q-motif and DEAD-box mutants, respec-
tively. As shown in Fig. 3, A and B, radiolabeled ATP cross-
linked to wild type Dhh1, andmutation of the Q-motif residues
Phe-66 and Gln-73 resulted in a reduction in ATP cross-link-
ing. We interpret the level of cross-linking remaining in this
mutant to be background levels. In addition, as observed with
eIF4A (54), the DEAD-box mutation (D195A) increased cross-
linking of ATP to Dhh1 2-fold.
Next, we analyzed the cross-linking of different nucleotides
to Dhh1 and its mutant derivatives. Because the level of back-
ground cross-linking to the different nucleotides can vary
depending on purity and the chemical nature of the nucleotide
bases, we compared the cross-linking of the nucleotides to the
wild type protein and the Q-domain mutant. Background
cross-linking would be equal in both versions of Dhh1. Consis-
tent with the data showing that Dhh1 can hydrolyze dATP, the
cross-linking of this nucleotide was similar to that of ATP. In
addition, cross-linking of dATP to the Q-motif mutant was
reduced (Fig. 3C). On the other hand, although some incorpo-
ration of radiolabeled CTP, GTP, and UTP into Dhh1 was
observed, the levels were equal for the wild type protein and the
two mutant derivatives (Fig. 3C). This suggests that the cross-
linking of CTP, UTP, and GTP arises from the nonspecific
interaction of these nucleotides with the protein and represents
background. The failure to detect specific cross-linking of
radiolabeled CTP, GTP, and UTP to Dhh1 is consistent with
the NTPase assays showing that Dhh1 cannot hydrolyze these
nucleotides (Fig. 2D).
Because the cross-linking efficiency of nucleotides differs, we
addressed nucleotide specificity by competition analysis.
Cross-linking was carried out with radiolabeled ATP and 200-
fold cold competitor nucleotides. Excess cold ATP, dATP, and
ADP competed equally well in the cross-linking assay, reducing
the level to 40–50% of that observed without competitor. The
amount of cross-linking detected in the presence of excess ade-
nine-containing nucleotides is approximately the same as that
observed to the Q-motif mutant in the absence of competitor
(Fig. 3D); thus, this likely represents background levels. GTP
competed reasonably well but CTP and UTP less so. Even
though some competition for binding was observed, Dhh1 was
incapable of hydrolyzing these nucleotides (Fig. 2D). Overall,
our analysis indicates that Dhh1 has a strong preference for
adenine-containing nucleotides.
Dhh1 Binds RNA with High Affinity—Next, we sought to
characterize the RNA binding properties of Dhh1. Dhh1 dis-
plays RNA-dependent ATPase activity, and a previous report
showed that it binds to poly(U) RNA using a semiquantitative,
filter binding assay (44). The published account used only a
fixed amount of RNA in the filter binding assays and did not
measure the affinity or length requirement for binding. We
used the highly sensitive and quantitative fluorescence polar-
ization assay to measure the RNA binding affinity and length
dependence. Dhh1 was titrated into a buffer containing a 3-
fluorescein-labeled poly(U) oligomer, and mP was recorded.
The dissociation constant (Kd) for the binding of Dhh1 to RNA
Characterization of the DEAD-box Protein Dhh1































































































































FIGURE 3. Analysis of UV-cross-linking of nucleotides to Dhh1. A, assays contained 4 M protein and 10 Ci of -32P-radiolabled nucleotide. Samples were
cross-linked on ice (254-nm UV radiation) for 6 min and resolved in a 10% SDS-PAGE gel. The gel was stained with Coomassie Blue, dried, and exposed to a
PhosphorImager screen. The 32P signal is shown on the left, and the Coomassie Blue-stained gel is shown on the right. B, quantification shown is of ATP
cross-linking from three experiments. Data are expressed as relative ATP cross-linking compared with that of wild type Dhh1, which was set to 1.0. Cross-linking
was corrected for the amount of total protein detected in the Coomassie Blue-stained gels. C, relative cross-linking of wild type and mutant proteins to NTPs
is shown. In each case cross-linking to wild type Dhh1 is set to 1. D, nucleotide competition experiments are shown. Wild type Dhh1 was incubated with excess
cold nucleotide indicated in the panel on the x axis. Radiolabeled ATP was added, and cross-linking was carried out as described in panel A.
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was calculated by plottingmP as a function of Dhh1 concentra-
tion and fitted to a rectangular hyperbola.
Dhh1 bound a 20-base polyuridine RNA (rU20) with high
affinity, displaying a Kd of 2 nM (Table 1). Thus, Dhh1 has a
very high affinity for RNA. Cheng et al. (44) reported that the
trypsin sensitivity of Dhh1 changed in the presence of ATP,
suggesting that it undergoes a conformational change upon
binding the nucleotide. The consequences of the conforma-
tional change are not known, but it could affect RNA binding
affinity by altering the positioning of the two lobes that form the
RNA binding cleft. Thus, we examined if nucleotides affected
RNA binding by conducting binding assays in the presence and
absence of ATP, ADP, and AMP-PNP. No changes in affinity of
Dhh1 for RNAwere observed in the presence of ATP, and only
a slight change was detected when ADP or AMP-PNP was
included (Table 1). Therefore, even though there is evidence
that ATP binding changes the conformation of Dhh1, this does
not affect RNA binding affinity significantly.
The crystal structure of the core domain of Dhh1 was solved
without RNA, but co-crystal structures of other DEXD/H-box
proteins with RNA have been solved. We, therefore, used the
crystal structure of D. melanogaster Vasa, a homologous
DEAD-box protein, to conduct structure-guided mutagenesis
to provide evidence that Dhh1binds RNA similarly. Vasa binds
10 bases of RNA by bending it into a groove formed between
the two globular domains of the protein (58). Importantly, the
locations of the charged residues in Vasa that contact RNA are
conserved in Dhh1 and are located in a cleft formed between
the N- and C-terminal domains of the core of Dhh1 (44). To
provide evidence that Dhh1 recognizes RNA through a similar
mechanism,we analyzed the RNA length requirement and con-
ductedmutagenesis of a subset of these conserved residues (see
below). Fluorescence polarization experimentswere conducted
using poly(U) probes of differing lengths (rU5, rU7, rU8, rU10,
rU12, and rU20). The data presented in Table 2 show that the
affinity of Dhh1 for RNA is length-dependent and generally
increased with increasing lengths of nucleic acid. Interestingly,
there was a significant decrease in affinity when the length of
RNA was reduced from 12 to 10 nucleotides (Table 2). The
affinity dropped further when the RNA was shortened to eight
nucleotides. Thus, the length requirement for RNA binding
detected in the binding assays generally agrees with the mini-
mal number of nucleotides contacting the protein in the co-
crystal structures of analogousDEXD/H-boxproteins andRNA
(58, 62). However, Dhh1must make contact with more than 10
nucleotides of RNA because increasing the number of nucleo-
tides from 10 to 12 or 20 led to a further increase in affinity.
Finally, we examined the binding of Dhh1 to a single-stranded
deoxyribose nucleic acid probe. Dhh1 bound to a poly(dT20)
probe with high affinity (77 nM), but this is 30-fold lower
than the rU20 probe (Table 2). However, it is unclear if Dhh1
binds single-stranded DNA in vivo.
It was reported that mutation of basic residues lining the
potential RNA binding cleft in Dhh1 reduced RNA binding
(44). Specifically, mutation of Arg-89 or Lys-91 in motif I, Arg-
345 or Gly-346 in motif V, and Arg-370 in motif VI reduced
RNA binding when assayed by a filter binding assay. We veri-
fied and extended these studies by conducting mutagenesis of
residues in Dhh1 implicated in RNA binding. Fluorescence
polarization binding assays largely confirmed that mutation of
the residues comprising the proposed RNA binding cleft
reduced RNA binding. However, a quantitative measure of Kd
values revealed that the effects of these mutations were not as
severe as what was implied from the filter binding assay (44).
Arginine 322 and serine 340were also targeted formutagenesis.
These amino acids correspond toArg-528 andThr-546 ofVasa,
which were shown to make direct contact with RNA in its co-
crystal structure with RNA (58). Mutation of these residues
individually did not affect RNA binding significantly (Table 3).
However, when both residues were mutated to alanines, RNA
binding affinity was reduced 4-fold compared with wild type
protein (Kd  82 nM for wild type protein versus 320 nM for
the R322A/S340A mutant). Collectively, the length depen-
dence for RNA binding and mutagenesis studies suggest that
the RNAbinding pocket ofDhh1 lies between theN- andC-ter-
minal domains and that it binds RNA similar to the related
DEAD-box protein Vasa.
We examined the ATPase activity of the RNA binding
mutants. The assays were carried out with saturating amounts
of RNA (20 g) to diminish the contributions of reduced RNA
binding on activity. All but one RNA binding mutant displayed
ATPase activities similar towild typeDhh1 (Table 3). The small
changes we observed in most mutants were within experimen-
tal error. However, the double R322A/S340A mutant showed
no specific ATPase activity, hydrolyzing ATP to the same level
as a DEAD-box (D195A) and ATP binding mutant (Q73A/
F66R). The reduction inATPase activity cannot be explained by
reduced ATP binding; the mutant cross-linked to ATP as well
as wild typeDhh1 or by the reduced affinity for RNA. The latter
point is supported by comparison of the two mutants with the
TABLE 1
Dhh1 binds RNA in vitro with high affinity
Wild typeDhh1 ormutant proteins were titrated into a binding assay containing 0.1
nM 3 fluorescein-labeled RNA or single-stranded DNA. Binding was measured by
monitoring the change in mP. The data were fit to a hyperbola, and a dissociation
constant was calculated from the curve. Dissociation constants for binding of Dhh1
to U20 (20-mer poly(U) containing a 3 fluorescein). Binding was carried out under
different conditions; that is, the presence/absence of Mg2 and ATP. Values are
expressed as the average and S.E. of three experiments.
Conditions Dissociation constant
nM
Protein  MgCl2 1.8  0.4
Protein  MgCl2  ATP 2.2  0.8
Protein  MgCl2  ADP 3.9  0.5
Protein  MgCl2  AMP-PNP 3.6  0.4
TABLE 2
Length dependence of RNA binding
Binding assays were conducted as described in Table 1 and under “Experimental
Procedures.” Dissociation constants for the binding of Dhh1 to sequences contain-
ing different lengths of poly ribose uridine (rU) and polydeoxyribose thymidine (dT)
nucleic acids are reported.
RNA length Dissociation constant
nM
rU5 968  317
rU7 577  112
rU8 405  54
rU10 81  8
rU12 5.4  0.5
rU20 2.7  0.6
dT20 77  9
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greatest reduction in RNA binding. The R322A/S340Amutant
displayed a slightly higher affinity for RNA than the R370A
mutant, yet the R370A mutant showed robust ATPase activity
when assayed in the presence of saturating amounts of RNA.
This suggests that Arg-322 and Ser-340 have additional roles in
ATP hydrolysis. Evidence for this possibility comes from stud-
ies of Drosophila DEAD-box protein Vasa. The orthologous
residues in Vasa are important for RNA binding, ATPase, and
helicase activities. The crystal structure of Vasa with RNA indi-
cates that these residues are important for bending the RNA in
the binding cleft. The bending of the RNAmay be important for
the ability of Vasa and Dhh1 to hydrolyze ATP; a similar model
has beenproposed by otherswhendescribing themechanismof
other DEXD/H helicases (38). Interestingly, the double mutant
K91A/T344A mutant bound RNA somewhat better than the
single K91A mutant. Although Lys-91 contributes to RNA
binding via an interactionwith the negatively charged RNA, the
increased flexibility caused by disruption of the interdomain
interactions in the K91A/T344Amutant may allow the RNA to
make contacts with other residues in the presumed RNA bind-
ing cleft, leading to higher affinity for RNA.
Dhh1Does Not Display Helicase Activity in Vitro—Our stud-
ies thus far show that Dhh1, like many DEXD/H-box proteins,
binds to RNA and hydrolyzes ATP in an RNA-dependent man-
ner.We next sought to examine if Dhh1 has helicase activity. It
cannot be taken for granted that Dhh1 displays helicase activity
because many DEXD/H-box proteins do not display helicase
activity. We used an assay to detect the unwinding of double-
stranded RNA containing either a 5 or 3 overhang. Our pre-
vious experiments have shown that Dhh1 can bind a 12-mer
RNA with high affinity, so we designed duplex (8 base) sub-
strates to incorporate a 12-nucleotide single-stranded RNA
overhang. We titrated various concentrations of wild type
Dhh1 (0.3, 0.6, and 1.0M) into the assay and carried out exper-
iments with 1 M K91A/T344A and D195A/E196A mutants.
The K91A/T344A mutant was tested to determine whether
enhancing ATPase activity could activate helicase activity. We
failed to observe unwinding of short double-stranded RNAs
with templates containing either a 5 or 3 overhang (supple-
mental Fig. 1). As a control we used the hepatitis C virus NS3
protein that unwinds double-stranded RNAwith a 3 overhang.
Under our reaction conditions 0.5 M NS3 specifically
unwound double-stranded RNA with a 3 overhang but not a
substrate with a 5 overhang, the same specificity that was
described earlier (45) (supplemental Fig. 1). Because Dhh1
bound more strongly to a 20-mer RNA, we repeated the assay
using substrate with a 20 nucleotide ssRNA overhang either at
the 5 or 3 ends but failed to observe any Dhh1-dependent
unwinding of substrates (not shown). Once again, hepatitis C
virus NS3 unwound the substrate with a 20-mer 3 overhang
(not shown). Thus, Dhh1 did not display helicase activity under
the conditions used here.
Phenotypic Screening of Dhh1 Mutants—Biochemical analy-
sis of Dhh1 has identified residues that are required for ATPase
activity, RNA binding, and ATP binding. Earlier studies have
shown that a DHH1 null mutant is viable but displays sensitiv-
ities to stress conditions including heat and DNA-damaging
agents such asmethylmethane sulfonate, hydroxyurea, andUV
irradiation (27, 28, 30).Mutations to theDEAD-box or residues
implicated in RNA binding could not complement the temper-
ature sensitivity of a dhh1 strain (44). We applied the same
analysis to the mutants we characterized biochemically and
examined their ability to complement the DNA damage sensi-
tivity of thedhh1 strain. It is a formal possibility that the DNA
damage resistance functions of Dhh1 may require different
functional domains than those required for heat stress. Wild
type Dhh1 or mutant proteins were expressed under the con-
trol of its ownpromoter from lowcopy plasmids in adhh1null
strain. A schematic of the mutants in relation to the nine con-
served functional motifs of Dhh1 is shown in Fig. 4A. Further-
more, we verified by Western blotting that each of the Dhh1
mutants accumulated to levels equal to that of wild type Dhh1
(Fig. 4B). As a whole, the data show that mutating any of the
conserved domains of Dhh1 resulted in DNA damage and heat
stress sensitivity. Those showing the strongest phenotypes typ-
ically displayed severely impaired ATPase activity. The R322A
mutation, which reduced RNA binding and ATPase weakly,
still showed sensitivity to stress conditions. However, reducing
RNA binding by as much as 5-fold did not affect the stress
resistance of the R370A mutant. This suggests that either the
TABLE 3
Comparison of biochemical activities of Dhh1 and its mutant derivatives
The mutants of Dhh1 are listed in the table. The mutants are shown in the table and are grouped according the contributions they make to the function of the protein,
predicted by its comparison to analogous DEAD-box RNA helcases. ATPase activities were carried out as described before. Moles of ATP hydrolyzed by the proteins are
shown. ATP binding was determined by UV-cross-linking assays, and the cross-linking of ATP to wild type Dhh1 was set to 1.0. Cross-linking of ATP by mutant proteins
is expressed relative to that of wild type Dhh1. RNA binding was assayed using 0.1 nM 3 fluorescein-labeled single-stranded 10-mer poly(U). Dissociation constants (nM)
calculated from binding curves are tabulated. Errors represent the average and S.D. of at least three independent experiments. ND, not determined.
Activity Dhh1 ATP hydrolyzed Relative cross-linking to ATP Dissociation constant for rU10 binding
pmol nM
WTDhh1 90  10 1 82  9
ATP binding Q73A 75  11 0.66  0.2 85  4
Q73A/F66R 42  14 0.51  0.1 91  12
ATP hydrolysis K96A 31  5 0.85  0.03 ND
D195A 35  4 2.15  0.3 120  20
RNA binding R322A 76  20 0.92  0.2 128  10
S340A 76  23 0.84  0.3 69  3
R322A/S340A 26  10 1.13  0.2 316  20
R370A 130  45 0.91  0.1 402  45
Interdomain interactions K91A 124  27 1.19  0.1 219  13
T344A 109  21 1.08  0.1 48  5
K91A/T344A 270  75 1.07  0.2 136  21
G346A 33  8 1.02  0.1 68  7
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amount of RNA within the cell is saturating or, more likely,
other factors in the cell compensate for its reduced affinity for
RNA. This mutant did display a weak RNA turnover defect (see
below), however, suggesting that mutating this residue does
have a subtle affect on Dhh1 function. The K91A/T344A and
the K91A mutants, which displayed increased ATPase activity,
FIGURE 4. Phenotypic analysis of Dhh1 mutants. A, a schematic shows the conserved domains in Dhh1 with the position of residues that were mutated.
B, analysis of the expression of Dhh1 mutants is shown. Western blotting using anti-Dhh1 antibody is shown. The amount of TATA-binding protein (TBP) was
used as a loading control. C, yeast cells expressing wild type or mutant DHH1 were grown in SD-tryptophan, and 3-fold serial dilutions of cultures were spotted
onto SD-tryptophan plates (control) or the same medium containing 75 mM hydroxyurea (HU) or 0.01% methyl methane sulfonate (MMS). UV sensitivity was
measured by exposing a plate to 60 J/m2 UV radiation. For testing heat sensitivity, plates were incubated at 37 °C. Control plates were incubated at 30 °C. The
mutants were tested in two groups; a wild type strain and deletion mutant was analyzed in each group.
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were not sensitive to stress. Interestingly, the K91A/T344A
mutant showed slightly better growth at 37 °C than cells
expressing wild type Dhh1 (Fig. 4C). The growth advantage of
this mutant at 37 °C is modest but reproducible.
The biochemical assays used Dhh1 protein retaining the
His6-tag and additional amino acids incorporated into the N
terminus. In contrast, the genetic analysis was carried out in
cells expressing the natural from of Dhh1. It is a formal possi-
bility the His6 tag changed the activity of the protein in vitro.
However, proteins generally tolerate tags in the N terminus,
and the biochemical activities and the expected phenotypes in
vivo of the Dhh1 mutants correlated very well (also see below).
Mutation of the Functional Domains of Dhh1 Affect RNA
Turnover—We isolated mutants with defects in the biochemi-
cal activities of Dhh1, and next we examined the requirement
for these functions in mRNA decay, recruitment into cytoplas-
mic foci, and binding to mRNA in vivo. Represen-
tative DHH1 mutants that displayed specific biochemical
defects were chosen for further analyses. The effect of these
mutations on RNA turnover was determined by measuring the
levels of GAL1mRNA over time after repressing transcription
with dextrose. GAL1 displayed an mRNA half-life of 11 min
in wild type cells, and deleting DHH1 extended the half-life to
22 min (Fig. 5A); these values agree with previous reports (11).
We observed that mutations in Dhh1 affecting ATP hydrolysis
(D195A/E196A), RNAbinding (R322A/S340A), andATP bind-
ing (F66R/Q73A) resulted in a doubling of half-life of theGAL1
mRNA, similar to that observed in the dhh1 mutant (Fig. 5A).
On the other hand, the half-life of GAL1 mRNA in the K91A/
T344Amutant was reproducibly shorter than that measured in
cells expressing wild type Dhh1, but the difference from the
wild type value is within experimental error (not shown). This
suggests that disrupting the interdomain interactions within
Dhh1 and enhancing its ability to hydrolyze ATP increased its
function in vivo. To further substantiate our results showing
that mutations in Dhh1 reduced mRNA turnover in vivo, we
studied the steady state levels of EDC1 mRNA, which is sensi-
tive to the loss of Dhh1 (36, 44). Because monitoring steady
statemRNA levels is more straightforward, moremutants were
examined. Deletion of DHH1 caused a 2–2.5-fold increase in
EDC1 mRNA (Fig. 5B and Ref 44). Here we observed that
mutants that affect ATPase activity (D195A, D195A/E196A,
G346A, and K96A), ATP binding (F66R/Q73A), or RNA bind-
ing (R322A/S340A and R370A) led to an increased accumula-
FIGURE 5. All activities of Dhh1 are required for mRNA decay. A, shown is a half-life estimation of GAL1. Cells were grown overnight to an A600 of 0.8 in 1%
yeast extract, 2% peptone, and 20 g/ml adenine sulfate supplemented with 2% galactose and then shifted to 4% dextrose-containing medium to repress
GAL1 transcription. Samples were collected at different time points. Blots were probed with GAL1 and loading control, ScR1. GAL1 signal was normalized to the
amount of ScR1 signal to correct for loading. To calculate half-life, a 0-min time point for each set was set to 100%, and the log of the amount of transcript was
plotted as a function of time. B, shown is accumulation of ECD1 mRNA, a known target of Dhh1. Northern blot analysis to detect EDC1 and ScR1 (loading control)
transcripts was carried out. EDC1 signal was normalized to the amount of ScR1. Values were normalized to the wild type signal, which was set to 1. Bars represent
the average and S.D. of at least three experiments.
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tion of EDC1 mRNA, indicating impaired decay functions in
these mutants (Fig. 5B). Interestingly, the steady state levels of
EDC1mRNAwere slightly reduced inmutants containing sub-
stitutions in residues involved in forming the interdomain
interactions (K91A and K91A/T344A) between the N- and
C-terminal lobes. The reduction in mRNAmay be the result of
enhanced turnover of EDC1mRNA. These results indicate that
disrupting any of the biochemical activities of Dhh1 leads to
defects in mRNA turnover and that the interdomain interac-
tionswithinDhh1may limit its ability to contribute to the turn-
over mRNAs in vivo (see below also).
The Localization of Dhh1 into Cytoplasmic Foci Is Regulated
by ATP and RNA Binding and Intermolecular Interactions—
The role of Dhh1 in mRNA turnover and translational repres-
sion has been attributed to its localization to cytoplasmic foci
called P-bodies, where it interacts with components of the
mRNA decapping machinery (Dcp1/Dcp2), Pat1, and Xrn1
(11). Dhh1 is localized throughout the cytoplasm in a punctate
pattern and can be redistributed into larger discrete foci upon
cell stress (25). It is not known which activities of Dhh1 are
required for its localization to P-bodies. To address this ques-
tion, we analyzed Dhh1 and its mutants’ ability to form P-bod-
ies in resting and stressed cells.We constructed strains contain-
ing C-terminal GFP-tagged Dhh1 at its genomic locus and
transformed the wild type and mutant strains with a plasmid
carrying RFP-tagged Dcp2, a reliable and easily visualized com-
ponent of yeast P-bodies (52). Stress was induced by starving
cells of dextrose, a condition that strongly and rapidly induces
P-body formation (25, 52). The stressed or unstressed cellswere
immediately imaged using a confocal fluorescence microscope
to visualizeDhh1- andDcp2-containing foci (25). In addition to
monitoring Dhh1 localization in cytoplasmic foci, we con-
ducted RIP assays to monitor the association of Dhh1 with
mRNAs in vivo. The procedure uses formaldehyde to rapidly
cross-link cells in culture to preserve RNA-protein interactions
and provides an effective method to measure the association of
Dhh1 with mRNAs. In conjunction with monitoring Dhh1
localization, RIP can correlate mRNA binding with P-body for-
mation in cells. Furthermore, as we will demonstrate by the
correlation between Dhh1 cross-linking and the extent of foci
formation in wild type andmutant cells, this method provides a
more quantitative surrogate to measure the recruitment of
Dhh1 into RNA-containing foci.
In wild type cells very few cells displayed Dhh1-containing
foci under the resting condition (dextrose), but the foci were
increased in number and size when cells were deprived of dex-
trose and the fraction of cells with foci increased (Fig. 6). The
Dhh1 colocalized almost completely with the Dcp2-RFP, con-
sistent with previous results showing that Dhh1 localizes to
P-bodies in stressed cells (25) (Fig. 6). Correlating with the
increase in Dhh1-containing foci in response to stress, there
was an increase in the cross-linking of Dhh1 to amodel mRNA,
PYK1, in stressed cells (Fig. 7).
An analysis of the localization ofDhh1mutants yielded inter-
esting results. First, in the ATPase-defective mutant (D195A/
E196A), an increase in the size and number of Dhh1-containing
foci was observed in resting cells (Fig. 6). Under stress, an
increase in foci intensity was observed. The differences in foci
between thismutant andwild type cells were not obvious under
stress conditions. However, the size and number of P-bodies
may have been close to saturation under the stressed condition;
therefore, the differences between the wild type andmutant are
not easily observed. Dcp2-RFP fluorescence overlapped that of
Dhh1, indicating that the ATPase activity of Dhh1 is not
required for Dcp2 to shuttle into P-bodies. Examination of the
association of the DEAD-box mutant with mRNA using RIP
revealed an increase over wild type in resting cells, but even a
more dramatic increase was observed in stressed cells. The
cross-linking of the DEAD-box mutant was 2-fold higher than
that observed in wild type cells. The increase in size and num-
ber of foci and the elevated association of the mutant protein
with mRNA suggest that the ATPase activity and mRNA decay
functions of Dhh1 are not required for it to shuttlemRNAs into
P-bodies. However, the failure to hydrolyze ATP may prevent
the decay or release of the mRNAs and an accumulation of
Dhh1 and mRNAs into P-bodies. This hypothesis is supported
by the observation that impairing mRNA decay by deleting
decapping enzyme Dcp1 or the exonuclease Xrn1 likewise led
to an accumulation of Dhh1 into P-bodies in unstressed cells
(25, 64).
The GFP signal of the Q-motif mutant is similar and may be
slightly weaker than the wild type cells in the unstressed condi-
tion. However, a decrease in the number and size of Dhh1-
containing foci was observed when the cells were stressed by
dextrose deprivation compared with wild type cells (Fig. 6).
Calculation of the average size of mutant Dhh1-containing foci
revealed that they are on average half the size of those observed
in wild type cells (0.12 versus 0.25 m for the wild type). The
RIP experiments suggest that the association of the F66R/Q73A
mutant was similar to that of wild type Dhh1 in resting cells but
that the stress-induced increase in its association with mRNAs
was nearly abolished in this mutant (Fig. 7). These results are a
little surprising, as the Q-motif mutant displays no ATPase
activity and impaired mRNA decay functions similar to the
DEAD-box mutant, and yet its localization and RNA associa-
tion patterns are different from the DEAD-box mutant. Thus,
the localization and RIP studies suggest that ATP binding is
required for Dhh1 to bind mRNA in vivo and transport into
P-bodies. This suggests that ATP binding per se, and not
hydrolysis specifically, plays a role in regulating Dhh1 (see
“Discussion”).
Similar to theATP bindingmutant, the RNAbindingmutant
(R322A/S340A) also showed weaker background staining in
unstressed cells and formed smaller foci when cells were
stressed (Fig. 6). The foci formed by thismutantwere also about
half the size of those formed bywild typeDhh1 (0.14 versus 0.24
um). RNA-IP experiments revealed that thismutant displayed a
2-fold reduction in its cross-linking to PYK1mRNAboth in the
stressed and unstressed conditions (Fig. 7). These two pieces of
data argue that the interaction of Dhh1 with RNA is required
for its recruitment into P-bodies. Furthermore, because this
mutant is defective for mRNA decay (Fig. 5), simply altering
mRNA turnover and accumulating RNAs in the cell cannot
cause the recruitment of Dhh1 into cytoplasmic foci. Further-
more, the pattern of Dcp2 fluorescence in this mutant was sim-
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ilar to that of the wild type cells, indicating that reducing Dhh1
RNA binding does not significantly affect the recruitment of
Dcp2 into P-bodies.
Mutating residues involved in the interdomain interactions
enhanced ATPase activity, imparted a slight growth advantage







Dhh1-GFP Dcp2-RFP Merge Dhh1-GFP
- Dextrose + Dextrose
FIGURE 6. The localization of Dhh1 mutants to cytoplasmic foci requires residues involved in ATP and RNA binding. Dhh1-GFP and Dcp2-RFP were
analyzed by confocal fluorescent microscopy. Log phase wild type and Dhh1 mutants expressing endogenous GFP- tagged Dhh1 protein and Dcp2 (pRP1186)
were dextrose-deprived for 15 min, and live cell images were obtained. Dhh1-GFP, Dcp2-RFP, and merged images are shown in dextrose conditions.
Dhh1-GFP images are shown in dextrose condition. Exposures displayed in the panels were chosen so that the outline of the cells can be seen.
FIGURE 7. RNA binding in vivo is affected by mutations in Dhh1. RIP analysis to study in vivo mRNA binding by Dhh1 is shown. Dhh1-cross-linked RNA was
extracted and converted to cDNA. Binding of Dhh1 to PYK1 mRNA was analyzed by PCR using primers to the ORF of PYK1. Percent IP was calculated by
correcting the IP RNA value for the input RNA value. The experiments shown in the left and right panels were conducted at different times; thus, the mutants
in each panel should be compared with the wild type data conducted in parallel.
Characterization of the DEAD-box Protein Dhh1
















in vivo. These phenotypes suggest that interdomain interac-
tions limit Dhh1 activity in vivo. Interestingly, we observed an
increase in foci formation in a greater fraction of unstressed
cells expressing the K91A/T344A mutant (Fig. 6). A slight
increase in the number and intensity of P-bodies under stressed
conditions was observed, but the increase was not robust. Sim-
ilar to the DEAD-box mutant, foci formation may be saturated
in cells under these conditions, and enhancement is not
detected. The most striking result was observed in the RIP
experiments. Disrupting interdomain interactions led an
3-fold increase in the cross-linking of the mutant to PYK1
mRNA in unstressed cells, and the level increased further upon
stress (Fig. 7). The increased association of the mutant with
mRNA is not caused by differences in the expression of the
mutant or an increase in its affinity for RNA. Thismutant accu-
mulates in the cells to the same level aswild typeDhh1 (Fig. 4B),
and it has a slightly lower affinity for RNA (Table 3). These
results argue that interactions between the N- and C-terminal
RecA-like domains in the core of Dhh1 may play an important
regulatory function in vivo, perhaps preventing Dhh1 from
binding mRNAs and shuttling into P-bodies, thereby restrict-
ing mRNA decay in unstressed cells.
DISCUSSION
Dhh1 Is a Bona FideDEAD-box Protein with ATPase Activity—
The classification of Dhh1 as a DEAD-box RNA helicase was
based on the presence of well annotatedmotifs characteristic of
this family of enzymes (37). It was surprising that a character-
ization of the ATPase activity of Dhh1 or any of its orthologues
has not been described. This is especially true given that the
protein has been expressed in quantities sufficient for struc-
tural studies, and a preliminary analysis of its RNA binding
abilities was conducted (44). Comparison of the crystal struc-
ture of Dhh1 to those of other RNA helicase revealed a distinct
difference in the organization and interactions between the two
N- and C-terminal lobes of the core domain. Significant inter-
actions between residues in the N- and C-terminal domains
were observed in the crystal structure Dhh1, which were not
seen in other DEAD-box proteins whose structures have been
solved (44). These interactions have the potential to “lock”
Dhh1 into an inactive conformation. The prevailing hypothesis
of how DEAD-box proteins hydrolyze ATP is that the binding
of ATP and RNA to the protein results in a conformational
change, bringing theN- andC-terminal domains together. ATP
hydrolysis is coupled to the concomitant movement of these
domains with respect to each other (55). The previous failures
to demonstrate ATPase activity and the interdomain interac-
tions detected in the crystal structure of Dhh1 raised the possi-
bility that it is not a typical DEAD-box protein or that the gene
evolved over time to lose its ATPase and helicase activities.
Thus, it was important to show that Dhh1 is a bona fideDEAD-
box protein with ATPase activity.
A comparison of the ATPase activity of Dhh1 to that of other
well characterized RNA helicases (53, 54, 65, 66) indicates that
it is a weak ATPase. We surmised that the interdomain inter-
actions could restrict the movement of the N- and C-terminal
domains of Dhh1 and, hence, reduce its ATPase activity. Anal-
ysis of a double K91A/T344Amutant and to a lesser extent the
single mutants showed that disrupting interdomain interac-
tions increased ATPase activity. In addition to providing an
explanation for the weak ATPase activity of the wild type pro-
tein, this result also corroborates the existing models that pre-
dict that the enzymatic activity of DEAD-box proteins requires
the coordinated movement of the two RecA-like helicase
domains. The ATPase activity of the interdomain interaction
mutant was still less than that observed for more robust heli-
cases. This is not surprising because there aremultiple residues
that form interdomain interactions between the two lobes of
Dhh1 (44). Mutagenesis of more residues to further disrupt the
interaction between the N and C lobes to increase activity to a
higher level is not practical as some of the residues may play
other roles in the function of the protein, such as RNA binding.
Any gains in ATPase activity caused by disrupted interdomain
interactions might be offset by reducing other activities
required for ATPase activity.
Dhh1DoesNot ShowHelicaseActivity inVitro—The classical
definition of an RNA helicase is a protein that binds ATP and
RNA, hydrolyzes ATP, and unwinds duplexed RNA. Our stud-
ies thus far have confirmed all of these activities for Dhh1,
except for the helicase activity. In our hands Dhh1 could not
unwind double-stranded RNA under multiple assay conditions
and using different substrates (supplemental Fig. 1 and data not
shown). Our failure to detect helicase activity is not unusual.
Many DEXD/H-box proteins have been classified as RNA heli-
cases based on sequence and structural similarities to DNA
helicases and their ability to hydrolyze ATP and bind RNA (39).
However, only a subset of these proteins has been shown to
unwind dsRNA in vitro (42, 43, 67, 68). It is clear that the
ATPase activity is required for Dhh1 to carry out its functions
in vivo, becausemutantswith substitutions in theDEAD-box or
other residues required for ATP hydrolysis cannot restore the
function of Dhh1 in stress resistance or mRNA decay. Like
many other examples where helicase activity of a DEAD-box
protein was not observed, it is unclear if this is due to technical
limitations of the assay or that the protein uses the conforma-
tional change associatedwithATP hydrolysis to carry out other
functions. For example, a growing number of helicases have
been shown to disrupt or remodel RNA-protein interactions
(69). Our mutational analysis and the work of others indicates
that Dhh1 regulates the shuttling ofmRNAs between the trans-
latable pool and the non-translatable pool contained in cyto-
plasmic foci (23, 26). Logically, this would require the assembly
and disassembly of mRNAs into messenger ribonucleoprotein
complexes. Because the transport of Dhh1 in and out of cyto-
plasmic foci is regulated by its RNA binding and ATPase activ-
ities, respectively, ATP hydrolysis may play a role in assembling
and disassembling mRNP particles rather than unwind duplex
RNA. Dhh1 orthologues may play similar functions. The Xeno-
pus orthologue Xp54 has been shown to shuttle between the
nucleus and cytoplasm in a developmentally regulated manner
whereby it interacts with nascent transcripts in the nuclei of
transcriptionally active oocytes and localizes to the cytoplasm
in transcriptionally quiescent oocytes (70). Also, studies inDro-
sophila, trypanosomes and clam have shown that Dhh1 ortho-
logues repress translation of maternal mRNAs during early
development (71–73). An attractive model for the control of
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mRNAs byDhh1 is that it does not act as a canonical helicase to
unwind RNA but as a protein that binds the RNAs with high
affinity and controls the transport of these RNAs into cytoplas-
mic foci, thereby sequestering them from the translation
machinery.
Activities Required for mRNA Decay and P-body Formation—
One of the aims of this study was to analyze how disabling the
known biochemical activities of Dhh1 affect its functions in
vivo. A synopsis of the phenotypes of the mutants is presented
in Table 4. Previous studies have partially addressed this issue
(44).Wehave expanded this analysis to include a greater variety
of mutants, including those in the ATP binding Q-motif and
residues involved in interdomain interactions. For the most
part we have confirmed that the biochemical activities and con-
servedmotifs in Dhh1 are required for stress resistance and the
regulation of mRNA decay in vivo. Some Dhh1 mutants with
amino acids substitutions in conserved domains failed to dis-
play strong phenotypes in the growth assays. This is not surpris-
ing, as mutation of these residuesmay not impair the activity of
the protein to a sufficient level to result in an observable phe-
notype. Herein lies the importance ofmonitoring the biochem-
ical activities of the mutants and confirming that they are
expressed to normal levels. There were cases where mutating
conserved residues led to a smaller decrease in biochemical
function/activity than others, and these partially activemutants
displayed weaker growth phenotypes in the growth assays (for
example the R370A mutant).
Whereas the importance of residues required for RNA bind-
ing andATPase activity (DEADbox) inmRNAdecay and stress
resistance functions was known (44), our characterization of
the mutants has shed some light on the role of the biochemical
activities in regulating mRNA decay, specifically the ability to
bind RNAs in vivo and localize into cytoplasmic foci. Dhh1 and
its metazoan orthologues are a major component of cytoplas-
mic processing bodies (23, 70). The function of these P-bodies
is not clear, but they have been connected to both translational
repression and mRNA decay (23). The size and abundance of
P-bodies is regulated by stress but also requires RNA and trans-
lation (25). Blocking translation inhibits P-body formation,
whereas impairing RNA decay causes increased P-body forma-
tion (26). This led to the hypothesis thatmRNAs are directed to
P-bodies for decay. However, data are mounting suggesting
that decay can occur outside of P-bodies (74). Dhh1 is proposed
to be a major regulator of RNA trafficking in and out of P-bod-
ies (23, 26). It was not known which of the Dhh1 activities was
required for it to be recruited to cytoplasmic foci. Herewe show
that the ATPase activity is not required for it to be recruited
into cytoplasmic foci but may be required for its release from
the foci. Inactivating Dhh1 ability to hydrolyze ATP actually
leads to increased mRNA binding in vivo, an increase in the
FIGURE 8. Model for the regulation of Dhh1 in vivo. Intermolecular interactions between the N- and C-terminal lobes (indicated by red line) limit ATP
hydrolysis until Dhh1 is activated by cellular factors in response to cell stress. Breaking the intermolecular interactions allow rotation of the two domains, ATP
hydrolysis, and release of the RNA (black line). Dhh1 is then released back into the free pool.
TABLE 4
Qualitative summary of the biochemical activities and phenotypes of Dhh1 mutants
The biochemical activities were derived from Table 3, RNA turnover was from Fig. 5, mRNA binding was from Fig. 7, and foci formation was from Fig. 6. Additional plus
signs () indicate a gain of function, the minus sign () indicates a loss of function, and / designation indicates a reduction in function.











Wild type      
Q-motif ATP binding Q73A/F66R - -  - / /
DEAD-box ATP hydrolysis D195A/E196A -   -  
RNA binding/ATP hydrolysis R322A/S340A -  / - / /
Interdomain interactions K91A/T344A      
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number of cells showing Dhh1-containing cytoplasmic foci in
unstressed cells and a slight increase in the intensity of the foci
that are produced when under stress (Figs. 6 and 7). The ability
of Dhh1 to hydrolyze ATP is important for Dhh1 to release
mRNAs and possibly cycle out of P-bodies. On the other hand,
mutants in Dhh1 that weaken its binding to RNA in vitro cor-
respondingly lead to reduced mRNA association and its ability
to concentrate into cytoplasmic foci. A possible explanation for
these observations is that Dhh1 binds mRNAs and transports
them to cytoplasmic foci for degradation or translational
repression, and activation of its ATPase activity by cellular fac-
tors localized in the foci results in its release from the RNAs and
the P-body (Fig. 8).
An interesting observationwasmade from the analysis of the
Q-motif mutant (F66R/Q73A) that has impaired ATP binding
andATPase activity, especially when compared with that of the
DEAD-boxmutant. The in vivomRNAbinding and localization
phenotypes are nearly opposite those of theDEAD-boxmutant.
The difference between these two mutants is that the DEAD-
box mutant displays enhanced ATP binding (cross-linking),
whereas the Q-motif mutant shows reduced binding. This
raises the interesting possibility that the binding of ATP to
Dhh1 regulates its function in vivo without the need to hydro-
lyze ATP. Interestingly, Cheng et al. (44) reported that the
binding of ATP to Dhh1 changes its sensitivity to digestion by
trypsin, suggesting the binding of ATP induces a conforma-
tional change in the protein. An ATP-induced conformational
change in Dhh1 may regulate its localization in the cell directly
or by altering its ability to associate with other cellular factors.
Interdomain Interactions Restrict Dhh1 Activity—We pres-
ent evidence that interdomain interactionswithinDhh1 at least
in part attenuate its ATPase activity and restrict its function in
vivo. Given that all the essential DEAD-box protein motifs are
well conserved in Dhh1, this suggests that this may be an evo-
lutionary adaptation with functional consequences. Dhh1 is an
abundant protein, expressed at 40,000 copies per cell (75).
Restricting its ATPase activity through intermolecular interac-
tions may control its function in vivo. Interestingly, it has been
shown that expression of Dhh1 from the highly active GAL1
promoter causes growth arrest (26). This observation suggests
that unregulated or hyperactive Dhh1 activity is detrimental to
cells.
The adaptations to Dhh1 that restricts its ATPase hydrolysis
but allows it to bind both RNA and ATP could be a means to
regulate this protein. For example, as mentioned above, Dhh1
may be involved in shuttling RNAs in and out of cellular com-
partments. These activities may require both RNA and ATP
binding but not ATP hydrolysis. InhibitingATP hydrolysismay
allow time for the Dhh1-RNA complex to be transported to its
destination where it could be subsequently acted upon by cel-
lular factors or post-translational modifications (Fig. 8). Inter-
estingly, it was recently proposed that the ATPase activity of
Xenopus p54many regulate the balance between its association
with decay versus translation factors (76). There are a growing
number of examples where the activity of DEAD-box proteins
is regulated by co-factors (38). The best characterized example
of this is the regulation of eIF4A by its binding partner eIF4G.
TheATPase activity of eIF4A is stimulated by eIF4G, and struc-
tural studies revealed that eIF4G stabilizes the helicase-compe-
tent conformation of eIF4A (63, 77). Although we do not have
direct evidence that Dhh1 is regulated by another factor, it is
known to associate with factors involved in mRNA decay and
translation. Restricting its activity until it enters cytoplasmic
foci (decay) or polysomes (translation) may allow tighter con-
trol of the protein, dictate its ability to regulate mRNA decay
versus translation, and protect the cell from unregulated activ-
ity of this abundant DEAD-box protein.
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N’ domain C’ domain
Strain Description Genotype 
PH499 WT MAT a  ade2-101; his3-∆200; leu2-∆1; ura3-52; trp1-∆63; lys2-801   
YJR148 DHH1 deletion PH499 with ∆dhh1::HIS3 
JR1429 Integrated DHH1 Isogenic to YJR148; DHH1::TRP1 
JR1430 Integrated  
F66R Q73A 
Isogenic to YJR148; dhh1 F66R/Q73A::TRP1 
JR1431 Integrated  
D195A E196A 
Isogenic to YJR148; dhh1 D195A/E196A::TRP1 
JR1432 Integrated  
K91A T344A 
Isogenic to YJR148; dhh1 K91A/T344A::TRP1 
JR1433 Integrated  
R322A S340A 
Isogenic to YJR148; dhh1 R322A/S340A::TRP1 
JR1450 Integrated DHH1-GFP Isogenic to YJR148; DHH1-GFP::KanMx 
JR1451 Integrated  
F66R Q73A-GFP 
Isogenic to YJR148; dhh1 F66R/Q73A-GFP::KanMx 
JR1452 Integrated  
D195A E196A-GFP 
Isogenic to YJR148; dhh1 D195A/ E196A-GFP::KanMx 
JR1453 Integrated  
K91A T344A-GFP 
Isogenic to YJR148; dhh1 K91A/T344A-GFP::KanMx 
JR1453  Integrated  
R322A S340A-GFP 
Isogenic to YJR148; dhh1 R322A/S340A-GFP::KanMx 
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Supplementary	  Figure	  1.	  Comparison	  of	  the	  biochemical	  activities	  of	  Dhh1	  and	  NS3	  helicase.	  	  
(A)	  ATPase	  activity.	  ATPase	  assay	  was	  performed	  at	  30	  °C	  for	  60	  minutes	  using	  4uMof	  Dhh1	  and	  
HCV	  NS3	  helicase	  and	  20	  ug	  poly	  (U)	  RNA.	  The	  activity	  was	  plotted	  as	  pmol	  of	  ATP	  hydrolyzed	  per	  
80	  pmol	  of	  protein.	  Details	  are	  found	  in	  the	  methods	  section	  of	  the	  m,anuscript.	  (B)	  Helicase	  assays	  
were	  carried	  out	  using	  2	  nM	  [32P]-­‐labeled	  3’	  and	  5’	  overhang	  substrates	  (B	  and	  C).	  Dhh1	  was	  
titrated	  into	  the	  assay	  from	  0	  to	  1	  μM	  (left	  side).	  Wild	  type	  Dhh1	  and	  mutants	  were	  analyzed	  at	  1	  
μM	  (middle).	  The	  NS3	  protein,	  a	  helicase	  from	  Hepatitis	  C	  virus	  was	  analyzed	  as	  control	  (0.5	  μM).	  
Reactions	  were	  performed	  at	  30°C.	  The	  trapping	  strand	  was	  included	  in	  the	  reactions	  (8-­‐mer	  RNA	  
that	  is	  complementary	  to	  the	  8	  bp	  displaced	  strand).	  Reactions	  were	  quenched	  after	  15	  minutes	  by	  
the	  addition	  of	  EDTA	  to	  100	  mM	  and	  SDS	  to	  0.33%.	  Products	  were	  resolved	  on	  native	  
polyacrylamide	  gels.	  	  
	  
Supplementary	  Figure	  2: Comparison of crystal structures of Dhh1 with that of eIF4A and 
mjDEAD. The crystal structures of Dhh1 (PDB id. 1S2M), S.	  cerevisae	  eIF4A (PDB id. 1FUU) and M. 
janaschii mjDEAD (PDB id. 1HV8) were analyzed using PyMOL. The positions of K91 and T344 are 
highlighted in the crystal structure of Dhh1. The position of orthologous residues in eIF4A and mjDEAD 
are highlighted in the respective crystal structures. K91 in Dhh1 is replaced by Q66 in eIF4A and R52 in 
mjDEAD, whereas T344 in the C’ domain of Dhh1 is replaced by A320 in eIF4A and S299 in mjDEAD. 
Unlike Dhh1, eIF4A and mjDEAD lack interdomain interactions. 
 
Supplementary Figure 3: Location of the mutants on the crystal structure of Dhh1. The crystal 
structure of Dhh1 was analyzed using PyMOL software (PDB id. 1S2M). The positions of amino acid 
residues that were mutated to alanines are color coded as follows: residues involved in ATP hydrolysis 
(K96, D195, E196 and R373) are highlighted in red, (F66 and Q73) involved in ATP binding are 
highlighted in orange, residues involved in interdomain interactions (K91 and T344) are highlighted in 
blue, residues that affect RNA binding (R322, S340 and R370), are shown in green and other residues 
(R89, R345 and G346) are shown in black. A schematic of the helicase domain structure of Dhh1 is 
shown below. 
	  
	  
